LUMIGAN

Manufacturer: Allergan, Inc.
Effective date: 2018-12-07
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 9
Source: full-release
Hydrated at: 2026-05-31 20:56:34

Label at a glance#

ProductLUMIGAN

Active ingredientBIMATOPROST

Label structure6 sections

Label contents#

Full prescribing information#

Principal Display Panel - 0.3 mg/1 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

®ALLERGAN

LUMIGAN®
(bimatoprost
ophthalmic solution)

0.03%

3 mL

sterile Rx only

®ALLERGAN LUMIGAN® (bimatoprost ophthalmic solution) 0.03% 3 mL sterile Rx only

Principal Display Panel - 0.3 mg/1 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ALLERGAN™

bimatoprost
ophthalmic solution

0.03%

LUMIGAN™

3 mL

sterile

ALLERGAN™ Rx BIMATOPROST OPHTHALMIC SOLUTION 0.03% LUMIGAN™ 3 mL sterile FOR EXTERNAL USE ONLY

Principal Display Panel - 0.3 mg/1 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

®ALLERGAN

LUMIGAN™

(BIMATOPROST
OPHTHALMIC
SOLUTION)
0.03%

3 mL

sterile

®ALLERGAN LUMIGAN™ (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% 3 mL sterile

Principal Display Panel - 0.3 mg/1 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

®ALLERGAN

LUMIGAN™

(BIMATOPROST
OPHTHALMIC
SOLUTION)
0.03%

3 mL

sterile

®ALLERGAN LUMIGAN™ (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% K 3 mL sterile

Principal Display Panel - 0.3 mg/1 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

®ALLERGAN

LUMIGAN™

(bimatoprost
ophthalmic solution
SOLUTION)
0.03%

3 mL

sterile

®ALLERGAN LUMIGAN™ (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% 3 mL sterile

Principal Display Panel - 0.3 mg/1 mL Carton Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

®ALLERGAN

LUMIGAN™

(bimatoprost 0.03%
Ophthalmic solution

3 mL

sterile

®ALLERGAN LUMIGAN™ (BIMATOPROST OPHTHALMIC SOLUTION) 0.03% 3 mL sterile

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
308739	bimatoprost 0.03 % Ophthalmic Solution	PSN	9
285128	LUMIGAN 0.03 % Ophthalmic Solution	PSN	9
285128	bimatoprost 0.3 MG/ML Ophthalmic Solution [Lumigan]	SBD	9
308739	bimatoprost 0.3 MG/ML Ophthalmic Solution	SCD	9
308739	bimatoprost 0.03 % Ophthalmic Solution	SY	9
285128	Lumigan 0.03 % Ophthalmic Solution	SY	9
285128	Lumigan 0.3 MG/ML Ophthalmic Solution	SY	9

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BIMATOPROST Pharmacologic Class Indexing	4	Indexing - Pharmacologic Class	20191108

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f71952f0-5c3a-ff37-f1fb-fed3868f6302	Product name	8	20260105
546f403c-5466-48b9-a79e-80b68d2b77d8	Product name	1	20200706
3471d048-4165-432e-a2dc-905eb43247db	Product name	4	20200611

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0023-9187-01	LUMIGAN	1 in 1 CARTON	SOLUTION/ DROPS	1	9
0023-9187-01	LUMIGAN	2.5 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	2.5	9
0023-9187-03	LUMIGAN	2.5 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	2.5	9
0023-9187-03	LUMIGAN	1 in 1 CARTON	SOLUTION/ DROPS	1	9
0023-9187-05	LUMIGAN	1 in 1 CARTON	SOLUTION/ DROPS	1	9
0023-9187-05	LUMIGAN	5 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	5	9
0023-9187-07	LUMIGAN	7.5 mL in 1 BOTTLE, DROPPER	SOLUTION/ DROPS	7.5	9
0023-9187-07	LUMIGAN	1 in 1 CARTON	SOLUTION/ DROPS	1	9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0023-9187	LUMIGAN (BIMATOPROST) SOLUTION/ DROPS [ALLERGAN, INC.]	9	8 package rows	20231216_ec9097e7-4be4-4e62-99c3-24b48244c9f2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0023-9187-03	ML - Milliliter	0023-9187	e8d2b926-5dbe-4c73-b7be-7ecfddaaadd0	1	2012-07-24
0023-9187-05	ML - Milliliter	0023-9187	1bc6d7e4-ef37-4f25-a0a7-f79059a3332e	1	2012-07-24
0023-9187-07	ML - Milliliter	0023-9187	84817ee4-9393-43e8-8408-a89d7e2aa461	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
bimatoprost	ACTIVE INGREDIENT	QXS94885MZ	1
bimatoprost	ACTIVE MOIETY	QXS94885MZ	1
benzalkonium chloride	INACTIVE INGREDIENT	F5UM2KM3W7	1
citric acid monohydrate	INACTIVE INGREDIENT	2968PHW8QP	1
hydrochloric acid	INACTIVE INGREDIENT	QTT17582CB	1
sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	1
Sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	1
sodium phosphate, dibasic	INACTIVE INGREDIENT	GR686LBA74	1
water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

LUMIGAN
bimatoprost
SODIUM CHLORIDE
BENZALKONIUM CHLORIDE
SODIUM PHOSPHATE, DIBASIC
CITRIC ACID MONOHYDRATE
WATER
SODIUM HYDROXIDE
HYDROCHLORIC ACID

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0023-9187	0023-9187-01, 0023-9187-03, 0023-9187-05, 0023-9187-07

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BIMATOPROST	QXS94885MZ	ACTIB
SODIUM CHLORIDE	451W47IQ8X	IACT
BENZALKONIUM CHLORIDE	F5UM2KM3W7	IACT
SODIUM PHOSPHATE, DIBASIC	GR686LBA74	IACT
CITRIC ACID MONOHYDRATE	2968PHW8QP	IACT
WATER	059QF0KO0R	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
HYDROCHLORIC ACID	QTT17582CB	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 582 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	CAPSULE, EXTENDED RELEASE / ORAL		41 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SUSPENSION / INTRA-ARTICULAR		45 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
sodium phosphate, dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	INJECTION / INTRADERMAL	0.2 %w/v		Exact identifier — unii candidate 14 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / URETERAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	OINTMENT, AUGMENTED / TOPICAL	0.11 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SYSTEM / TOPICAL	3.1 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, EMULSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
benzalkonium chloride	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SPRAY / NASAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	TABLET, FILM COATED / ORAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRAMUSCULAR		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / RESPIRATORY (INHALATION)		108 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL	226 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / SUBCUTANEOUS	1 %w/v		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRAVITREAL		6 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / INTRAVENOUS	18.25 mg		Exact identifier — unii candidate 148 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRALESIONAL		13 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	AEROSOL, FOAM / TOPICAL		1 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, SUSPENSION / INTRA-ARTICULAR		26 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
benzalkonium chloride	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION/ DROPS / TOPICAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SUSPENSION / RESPIRATORY (INHALATION)	0.03 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	POWDER, FOR SUSPENSION / ORAL		98 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION/ DROPS / TOPICAL	0.01 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / SUBMUCOSAL		17 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	SOLUTION / INTRAOCULAR	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRA-AMNIOTIC	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRAVENOUS		28773 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL	226 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INHALANT / RESPIRATORY (INHALATION)	3 mg		Exact identifier — unii candidate 134 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	GEL, METERED / TRANSDERMAL		350 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION / INTRAMUSCULAR		90 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOAP / TOPICAL	0.5 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
benzalkonium chloride	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION / AURICULAR (OTIC)	0.01 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	AEROSOL, FOAM / RECTAL		7 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / INTRAOCULAR		1 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SPRAY, METERED / NASAL		36 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SUSPENSION / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / DENTAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SUSPENSION / ORAL		269 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	LIQUID / ORAL		114 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / TOPICAL		39 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	LIQUID / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, EMULSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	INJECTION, SUSPENSION / INTRALESIONAL	ADJ PH		Exact identifier — unii candidate 148 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION / INTRALESIONAL	0.9 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	LOTION / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 134 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, SOLUTION / INTRAMUSCULAR		26 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / BUCCAL	NA		Exact identifier — unii candidate 88 equally ranked IID candidates
sodium phosphate, dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	INJECTION / SUBCUTANEOUS		14 mg	Exact identifier — unii candidate 14 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS		2922 mg	Exact identifier — unii candidate 134 equally ranked IID candidates
hydrochloric acid	HYDROCHLORIC ACID	QTT17582CB	AEROSOL, SPRAY / RESPIRATORY (INHALATION)	1.5 %w/w		Exact identifier — unii candidate 148 equally ranked IID candidates
citric acid monohydrate	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / SUBCUTANEOUS		28 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
Sodium hydroxide	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
sodium chloride	SODIUM CHLORIDE	451W47IQ8X	ELIXIR / ORAL	1 mg		Exact identifier — unii candidate 134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
a2b1c1ee-5c60-4485-8f60-f027d665139b			ec9097e7-4be4-4e62-99c3-24b48244c9f2	2018-12-07		Exact identifier spl id: a2b1c1ee-5c60-4485-8f60-f027d665139b spl set id: ec9097e7-4be4-4e62-99c3-24b48244c9f2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.